Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Persistent warts protected from immune attack by a blocking factor.

D L Freed, K E Eyres

    The British Journal of Dermatology
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease.

    Lancet (London, England)·1999
    Same author

    Do dietary lectins cause disease?

    BMJ (Clinical research ed.)·1999
    Same author

    Headache and Chiari I malformation in the pediatric population.

    Pediatric neurosurgery·1998
    Same author

    On arterial calcification.

    International journal of cardiology·1998
    Same author

    Little arrows.

    Lancet (London, England)·1996
    Same author

    Self experimentation.

    Lancet (London, England)·1987
    Same journal

    Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.

    The British journal of dermatology·2026
    Same journal

    Management Patterns and Repigmentation Outcomes in Pediatric Segmental Versus Non-segmental Vitiligo: A Single-center Retrospective Study (2015-2024).

    The British journal of dermatology·2026
    Same journal

    Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.

    The British journal of dermatology·2026
    Same journal

    Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

    The British journal of dermatology·2026
    Same journal

    Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

    The British journal of dermatology·2026
    Same journal

    Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

    The British journal of dermatology·2026
    See all related articles

    Severe warts resistant to therapy contain a soluble factor that blocks local cellular immunity. This discovery led to a novel therapy by infection, showing limited success in treating chronic warts.

    Area of Science:

    • Immunology
    • Dermatology
    • Virology

    Background:

    • Chronic warts present a significant therapeutic challenge due to high resistance to conventional treatments.
    • Understanding the immunological mechanisms underlying wart persistence is crucial for developing effective therapies.

    Observation:

    • A soluble factor was identified within severe, long-standing warts.
    • This factor was found to specifically inhibit the local expression of cellular immunity.
    • Systemic immune responses remained unaffected by the soluble factor.

    Findings:

    • The identified soluble factor acts as a local immunosuppressant in wart lesions.
    • This localized immune suppression contributes to the chronicity and therapeutic resistance of severe warts.

    Related Experiment Videos

    Implications:

    • The findings suggest a novel therapeutic strategy targeting the local immunosuppressive factor.
    • Therapy by infection was explored, demonstrating limited efficacy but validating the underlying hypothesis.
    • Further research is warranted to optimize therapies that overcome local immune evasion in viral infections.